Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Current Treatment Options in Oncology
|
March 21, 2022
Nectin-4: a Novel Therapeutic Target for Skin Cancers
Hiroki Hashimoto, Yuka Tanaka, Maho Murata, et al.
The Kobe Journal of Medical Sciences
|
March 5, 2009
Expression of beta-catenin and integrin-linked kinase in the mouse sciatic nerve
Junichiro Takeuchi, Yasuyuki Shibuya, Maho Murata, et al.
Biomedicines
|
April 3, 2021
Nectin Cell Adhesion Molecule 4 (NECTIN4) Expression in Cutaneous Squamous Cell Carcinoma: A New Therapeutic Target?
Yuka Tanaka, Maho Murata, Yoshinao Oda, et al.
BMC Medical Ethics
|
September 12, 2022
Current status of umbilical cord blood storage and provision to private biobanks by institutions handling childbirth in Japan
Maho Murata, Kenichiro Kawabe, Taichi Hatta, et al.
Scientific Reports
|
March 8, 2022
Nectin cell adhesion molecule 4 regulates angiogenesis through Src signaling and serves as a novel therapeutic target in angiosarcoma
Yuka Tanaka, Maho Murata, Keiko Tanegashima, et al.
International Journal of Molecular Sciences
|
August 23, 2020
NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic Target
Maho Murata, Takamichi Ito, Yuka Tanaka, et al.
International Journal of Molecular Sciences
|
January 22, 2021
NECTIN4: A Novel Therapeutic Target for Melanoma
Yuka Tanaka, Maho Murata, Che-Hung Shen, et al.
Journal of Clinical Medicine
|
February 29, 2020
OVOL2-Mediated ZEB1 Downregulation May Prevent Promotion of Actinic Keratosis to Cutaneous Squamous Cell Carcinoma
Maho Murata, Takamichi Ito, Yuka Tanaka, et al.
The Kobe Journal of Medical Sciences
|
November 11, 2010
A case of malignant melanoma of the oral cavity alive with liver metastasis for a long period with administration of a biologic response modifier, OK432
Masahiro Umeda, Maho Murata, Hiroaki Suzuki, et al.
Current Treatment Options in Oncology
|
February 9, 2021
BRAF Heterogeneity in Melanoma
Takamichi Ito, Yuka Tanaka, Maho Murata, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Current Treatment Options in Oncology
|
March 21, 2022
Nectin-4: a Novel Therapeutic Target for Skin Cancers
Hiroki Hashimoto, Yuka Tanaka, Maho Murata, et al.
The Kobe Journal of Medical Sciences
|
March 5, 2009
Expression of beta-catenin and integrin-linked kinase in the mouse sciatic nerve
Junichiro Takeuchi, Yasuyuki Shibuya, Maho Murata, et al.
Biomedicines
|
April 3, 2021
Nectin Cell Adhesion Molecule 4 (NECTIN4) Expression in Cutaneous Squamous Cell Carcinoma: A New Therapeutic Target?
Yuka Tanaka, Maho Murata, Yoshinao Oda, et al.
BMC Medical Ethics
|
September 12, 2022
Current status of umbilical cord blood storage and provision to private biobanks by institutions handling childbirth in Japan
Maho Murata, Kenichiro Kawabe, Taichi Hatta, et al.
Scientific Reports
|
March 8, 2022
Nectin cell adhesion molecule 4 regulates angiogenesis through Src signaling and serves as a novel therapeutic target in angiosarcoma
Yuka Tanaka, Maho Murata, Keiko Tanegashima, et al.
International Journal of Molecular Sciences
|
August 23, 2020
NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic Target
Maho Murata, Takamichi Ito, Yuka Tanaka, et al.
International Journal of Molecular Sciences
|
January 22, 2021
NECTIN4: A Novel Therapeutic Target for Melanoma
Yuka Tanaka, Maho Murata, Che-Hung Shen, et al.
Journal of Clinical Medicine
|
February 29, 2020
OVOL2-Mediated ZEB1 Downregulation May Prevent Promotion of Actinic Keratosis to Cutaneous Squamous Cell Carcinoma
Maho Murata, Takamichi Ito, Yuka Tanaka, et al.
The Kobe Journal of Medical Sciences
|
November 11, 2010
A case of malignant melanoma of the oral cavity alive with liver metastasis for a long period with administration of a biologic response modifier, OK432
Masahiro Umeda, Maho Murata, Hiroaki Suzuki, et al.
Current Treatment Options in Oncology
|
February 9, 2021
BRAF Heterogeneity in Melanoma
Takamichi Ito, Yuka Tanaka, Maho Murata, et al.
Page
of 5